Organization Name Myricx BioAnnounced Date Jul 8, 2024 Closed On Date Jul 8, 2024 Funding Type Series A Funding Stage Early Stage Venture Money Raised
Overview
Lead Investors
- Novo Holdings
Novo Holdings is a holding company specializing in life science investor with a focus on creating long-term value. - Abingworth
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs.
Investors
Recent News
donews.com — MyricxBio raises £90 million in Series A funding
BioWorld Financial Watch — Myricx raises £90M in Europe’s largest series A for NMT inhibitors